Over the past five years, scientists have slowly gained a better…
Category: COVID-19
Home /
Annual flu shots in the United States are going to be…
Research on the link between bats and human health has gained…
Funding unlocked during the COVID-19 pandemic allowed many countries in Asia…
As the world continues to grapple with the ongoing COVID-19 pandemic,…
This fall, the FDA approved the rollout of two updated Omicron-specific…
In the wake of the economic and human costs of the…
Japan, a country with a population, on average, 10 years older…
On March 11, 2020, the World Health Organization announced that COVID-19…
In a time when news headlines, academic journals, and science websites…
Thanks in large part to the efficacy of the Pfizer-BioNTech and…
The COVID-19 pandemic has prompted a boom in immunology research. One…
Cold and flu season is nearly here, with flu activity typically…
On September 22, 2021, the U.S. Food and Drug Administration (FDA)…
It is hard to believe that within one year of the…
Earlier this month, the United States reached a crucial milestone: Per…
In the first two blogs of this three-part series on how…
Like most viruses, SARS-CoV-2 infects its hosts by entering and “hijacking”…
Eighteen months have passed since the World Health Organization declared COVID-19…
As the COVID-19 pandemic spreads throughout the world, the scientific community…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
NEWARK, Delaware, June 10, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new clinical…
Battling COVID in the Lab: Mini-Lungs Yield Insights and Potential Prevention Pathways
September 23, 2024
Over the past five years, scientists have slowly gained a better understanding of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. Despite our knowledge of
COVID-19 Wiped Out a Flu Strain, Spurring Revamped Vaccine Strategy
April 8, 2024
Annual flu shots in the United States are going to be made a little differently this year, as one of the flu strains usually included
Can the Bat Genome Inform Pandemic Prevention?
May 17, 2023
Research on the link between bats and human health has gained significant attention in recent years due to the outbreaks of a number of zoonotic
Genome Sequencing Labs in Africa and Asia Expand Beyond COVID-19 to Endemic Diseases
February 27, 2023
Funding unlocked during the COVID-19 pandemic allowed many countries in Asia and Africa to perform in-house genome sequencing, resulting in faster results and action that
Can UV Light Replace Masks in the Fight Against COVID-19?
November 9, 2022
As the world continues to grapple with the ongoing COVID-19 pandemic, scientists continue to investigate a variety of potential treatments and prevention methods. Previous studies
Are the New COVID Boosters Better Than the Old Boosters?
November 2, 2022
This fall, the FDA approved the rollout of two updated Omicron-specific COVID-19 boosters. These new COVID boosters aim to provide more protection against the two
Evaluating the Costs and Benefits of COVID Lockdowns
October 24, 2022
In the wake of the economic and human costs of the COVID-19 pandemic and governments’ responses to the virus, researchers have tried to evaluate the
The Japan Model: Limiting the Impact of COVID Without Lockdowns
August 1, 2022
Japan, a country with a population, on average, 10 years older than that of the United States of America, experienced a comparably minimal impact from
COVID-19 and Data: Will We Apply the Lessons Learned?
July 25, 2022
On March 11, 2020, the World Health Organization announced that COVID-19 had reached pandemic status, and people around the globe struggled to understand the current
Back in Black: Understanding the Origins of the “Original Pandemic”
July 21, 2022
In a time when news headlines, academic journals, and science websites sharing the latest discoveries and theories about SARS-CoV-2 and its many variants demand our
The Potential of a Self-Amplifying mRNA Vaccine Is Heard Loud and Clear
June 13, 2022
Thanks in large part to the efficacy of the Pfizer-BioNTech and Moderna mRNA vaccines, mask mandates, social distancing, and other COVID-19-related precautions have eased in
Is Immune System Memory Good or Bad News for COVID-19?
February 14, 2022
The COVID-19 pandemic has prompted a boom in immunology research. One research question is whether a previous infection with a common-cold coronavirus helps the body
The Flu Shot and COVID: Will the Delta Variant Play a Role?
November 3, 2021
Cold and flu season is nearly here, with flu activity typically peaking between the months of December and February. But according to a recent poll
Will You Need a COVID-19 Vaccine Booster Shot?
October 13, 2021
On September 22, 2021, the U.S. Food and Drug Administration (FDA) approved a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for specific communities. This
When COVID-19 Vaccine Supply Doesn’t Meet the Need, Innovations Emerge
October 11, 2021
It is hard to believe that within one year of the declaration of the pandemic, as many as eleven COVID-19 vaccines received emergency authorized use.
COVID-19 Symptoms in the Vaccinated vs. Unvaccinated
October 6, 2021
Earlier this month, the United States reached a crucial milestone: Per the Centers for Disease Control and Prevention (CDC) website, 55 percent of the U.S.
How SARS-CoV-2 Spreads Infection So Efficiently | Part 3 – Invasion of the Variants
October 4, 2021
In the first two blogs of this three-part series on how SARS-CoV-2 spreads, QPS has covered how the SARS-CoV-2 spike protein can attach to and
How SARS-CoV-2 Spreads Infection so Efficiently | Part 2 – Hijacking Host Cells
September 20, 2021
Like most viruses, SARS-CoV-2 infects its hosts by entering and “hijacking” the operations of a host cell. A significant amount of the research on COVID-19
When Will COVID End?
September 15, 2021
Eighteen months have passed since the World Health Organization declared COVID-19 a pandemic on March 11, 2020. The pandemic has upended society as we know
How SARS-CoV-2 Spreads Infection So Efficiently | Part 1 – The Spike Protein
August 30, 2021
As the COVID-19 pandemic spreads throughout the world, the scientific community learns more about the SARS-CoV-2 virus and plans to use that information to develop
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
NEWARK, Delaware, June 10, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new clinical…
